Macfos [ROBU] vs Cyient DLM [CYIENTDLM] Detailed Stock Comparison
Macfos
BSE
Loading...
Cyient DLM
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Macfos wins in 12 metrics, Cyient DLM wins in 7 metrics, with 0 ties. Macfos appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Macfos | Cyient DLM | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.24 | 52.07 | Macfos |
| Price-to-Book Ratio | 9.72 | 3.55 | Cyient DLM |
| Debt-to-Equity Ratio | 28.49 | 31.73 | Macfos |
| PEG Ratio | 0.64 | 27.40 | Macfos |
| EV/EBITDA | 27.19 | 25.96 | Cyient DLM |
| Profit Margin (TTM) | 7.36% | 4.22% | Macfos |
| Operating Margin (TTM) | 11.19% | 5.22% | Macfos |
| EBITDA Margin (TTM) | 11.19% | 5.22% | Macfos |
| Return on Equity | 25.51% | 7.17% | Macfos |
| Return on Assets (TTM) | 16.61% | 4.02% | Macfos |
| Free Cash Flow (TTM) | $-294.48M | $-1.12B | Macfos |
| 1-Year Return | 3.31% | -44.71% | Macfos |
| Price-to-Sales Ratio (TTM) | 2.67 | 2.20 | Cyient DLM |
| Enterprise Value | $7.06B | $36.28B | Cyient DLM |
| EV/Revenue Ratio | 2.74 | 2.36 | Cyient DLM |
| Gross Profit Margin (TTM) | 24.04% | 40.21% | Cyient DLM |
| Revenue per Share (TTM) | $274 | $194 | Macfos |
| Earnings per Share (Diluted) | $20.13 | $8.17 | Macfos |
| Beta (Stock Volatility) | -0.28 | -0.32 | Cyient DLM |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Macfos vs Cyient DLM Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Macfos | -2.41% | -7.49% | -3.51% | -7.48% | -18.16% | -47.99% |
| Cyient DLM | -0.71% | -4.54% | -13.74% | -0.51% | -3.27% | -36.76% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Macfos | 3.31% | 355.76% | 355.76% | 355.76% | 355.76% | 355.76% |
| Cyient DLM | -44.71% | -15.23% | -15.23% | -15.23% | -15.23% | -15.23% |
Performance & Financial Health Analysis: Macfos vs Cyient DLM
| Metric | ROBU | CYIENTDLM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.87B | ₹33.83B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 8,445 | 139,828 |
| 90 Day Avg. Volume | 8,615 | 200,692 |
| Last Close | ₹711.90 | ₹422.45 |
| 52 Week Range | ₹671.10 - ₹1,528.20 | ₹378.60 - ₹840.80 |
| % from 52W High | -53.42% | -49.76% |
| All-Time High | ₹1,528.20 (Dec 09, 2024) | ₹883.80 (Feb 26, 2024) |
| % from All-Time High | -53.42% | -52.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.08% |
| Quarterly Earnings Growth | 0.26% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.04% |
| Operating Margin (TTM) | 0.11% | 0.05% |
| Return on Equity (TTM) | 0.26% | 0.07% |
| Debt to Equity (MRQ) | 28.49 | 31.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹75.06 | ₹119.72 |
| Cash per Share (MRQ) | ₹0.55 | ₹5.94 |
| Operating Cash Flow (TTM) | ₹-191,087,000 | ₹180.85M |
| Levered Free Cash Flow (TTM) | ₹179.19M | ₹680.76M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Macfos vs Cyient DLM
| Metric | ROBU | CYIENTDLM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.24 | 52.07 |
| Forward P/E | N/A | 25.18 |
| PEG Ratio | 0.64 | 27.40 |
| Price to Sales (TTM) | 2.67 | 2.20 |
| Price to Book (MRQ) | 9.72 | 3.55 |
| Market Capitalization | ||
| Market Capitalization | ₹6.87B | ₹33.83B |
| Enterprise Value | ₹7.06B | ₹36.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.74 | 2.36 |
| Enterprise to EBITDA | 27.19 | 25.96 |
| Risk & Other Metrics | ||
| Beta | -0.28 | -0.32 |
| Book Value per Share (MRQ) | ₹75.06 | ₹119.72 |
Financial Statements Comparison: Macfos vs Cyient DLM
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ROBU | CYIENTDLM |
|---|---|---|
| Revenue/Sales | ₹592.68M | ₹2.78B |
| Cost of Goods Sold | ₹450.22M | ₹1.66B |
| Gross Profit | ₹142.46M | ₹1.12B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹66.29M | ₹145.41M |
| EBITDA | ₹75.79M | ₹292.34M |
| Pre-Tax Income | ₹67.83M | ₹101.01M |
| Income Tax | ₹17.46M | ₹26.38M |
| Net Income (Profit) | ₹50.37M | ₹74.63M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ROBU | CYIENTDLM |
|---|---|---|
| Cash & Equivalents | ₹5.13M | ₹471.17M |
| Total Current Assets | ₹839.17M | ₹12.82B |
| Total Current Liabilities | ₹358.04M | ₹5.34B |
| Long-Term Debt | ₹13.72M | ₹1.95B |
| Total Shareholders Equity | ₹702.32M | ₹9.49B |
| Retained Earnings | N/A | ₹2.26B |
| Property, Plant & Equipment | ₹100.01M | ₹324.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ROBU | CYIENTDLM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ROBU | CYIENTDLM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 8,445 | 139,828 |
| Average Daily Volume (90 Day) | 8,615 | 200,692 |
| Shares Outstanding | 9.42M | 79.31M |
| Float Shares | 1.76M | 37.97M |
| % Held by Insiders | 0.70% | 0.56% |
| % Held by Institutions | 0.06% | 0.27% |
Dividend Analysis & Yield Comparison: Macfos vs Cyient DLM
| Metric | ROBU | CYIENTDLM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |